Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Crmp1 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Crmp1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CRMP1 mRNA | CTD | PMID:22206623 | Crmp1 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Crmp1 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of CRMP1 mRNA] | CTD | PMID:22206623 | Crmp1 | Rat | 17beta-estradiol | decreases phosphorylation | ISO | CRMP1 (Homo sapiens) | 6480464 | Estradiol results in decreased phosphorylation of CRMP1 protein | CTD | PMID:27026707 | Crmp1 | Rat | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CRMP1 mRNA | CTD | PMID:32741896 | Crmp1 | Rat | 17beta-estradiol 3-benzoate | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CRMP1 mRNA | CTD | PMID:32741896 | Crmp1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Crmp1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CRMP1 mRNA | CTD | PMID:21570461 | Crmp1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CRMP1 mRNA | CTD | PMID:34747641 | Crmp1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Crmp1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CRMP1 mRNA | CTD | PMID:33956508 | Crmp1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CRMP1 mRNA | CTD | PMID:32109520 and PMID:33387578 | Crmp1 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:19954255 | Crmp1 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Crmp1 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of CRMP1 mRNA | CTD | PMID:30951980 | Crmp1 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of CRMP1 mRNA | CTD | PMID:24780913 | Crmp1 | Rat | aflatoxin B1 | increases expression | ISO | CRMP1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of CRMP1 mRNA | CTD | PMID:22100608 | Crmp1 | Rat | Aflatoxin B2 alpha | affects methylation | ISO | CRMP1 (Homo sapiens) | 6480464 | aflatoxin B2 affects the methylation of CRMP1 intron | CTD | PMID:30157460 | Crmp1 | Rat | aldehydo-D-glucose | multiple interactions | EXP | | 6480464 | CRMP1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] | CTD | PMID:21124846 | Crmp1 | Rat | all-trans-retinoic acid | decreases expression | ISO | CRMP1 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of CRMP1 mRNA | CTD | PMID:21934132 | Crmp1 | Rat | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of CRMP1 mRNA | CTD | PMID:30779732 | Crmp1 | Rat | aripiprazole | increases expression | EXP | | 6480464 | Aripiprazole results in increased expression of CRMP1 mRNA | CTD | PMID:17868501 | Crmp1 | Rat | aristolochic acid A | increases expression | ISO | CRMP1 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of CRMP1 mRNA | CTD | PMID:33212167 | Crmp1 | Rat | benzo[a]pyrene | increases methylation | ISO | CRMP1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of CRMP1 exon and Benzo(a)pyrene results in increased methylation of CRMP1 promoter | CTD | PMID:27901495 | Crmp1 | Rat | benzo[e]pyrene | increases methylation | ISO | CRMP1 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of CRMP1 intron | CTD | PMID:30157460 | Crmp1 | Rat | beta-lapachone | increases expression | ISO | CRMP1 (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of CRMP1 mRNA | CTD | PMID:38218311 | Crmp1 | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CRMP1 mRNA | CTD | PMID:31199487 | Crmp1 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of CRMP1 mRNA | CTD | PMID:25181051 | Crmp1 | Rat | bisphenol A | decreases expression | ISO | Crmp1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of CRMP1 mRNA | CTD | PMID:32156529 | Crmp1 | Rat | bisphenol A | decreases expression | ISO | CRMP1 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of CRMP1 protein | CTD | PMID:37567409 | Crmp1 | Rat | bisphenol A | decreases methylation | ISO | CRMP1 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of CRMP1 gene | CTD | PMID:31601247 | Crmp1 | Rat | bisphenol A | multiple interactions | ISO | CRMP1 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of CRMP1 gene | CTD | PMID:31601247 | Crmp1 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CRMP1 mRNA | CTD | PMID:30816183 and PMID:34947998 | Crmp1 | Rat | bromobenzene | affects expression | EXP | | 6480464 | bromobenzene affects the expression of CRMP1 mRNA | CTD | PMID:32479839 | Crmp1 | Rat | butanal | increases expression | ISO | CRMP1 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of CRMP1 mRNA | CTD | PMID:26079696 | Crmp1 | Rat | Butylbenzyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CRMP1 mRNA | CTD | PMID:31199487 | Crmp1 | Rat | cadmium dichloride | increases expression | ISO | Crmp1 (Mus musculus) | 6480464 | Cadmium Chloride results in increased expression of CRMP1 mRNA | CTD | PMID:24982889 | Crmp1 | Rat | carbon nanotube | affects expression | ISO | Crmp1 (Mus musculus) | 6480464 | Nanotubes and Carbon affects the expression of CRMP1 protein | CTD | PMID:21135415 | Crmp1 | Rat | CGP 52608 | multiple interactions | ISO | CRMP1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CRMP1 gene] | CTD | PMID:28238834 | Crmp1 | Rat | chlordecone | increases expression | ISO | Crmp1 (Mus musculus) | 6480464 | Chlordecone results in increased expression of CRMP1 mRNA | CTD | PMID:29980752 | Crmp1 | Rat | chlorpyrifos | increases expression | ISO | Crmp1 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of CRMP1 mRNA | CTD | PMID:32715474 | Crmp1 | Rat | cisplatin | increases phosphorylation | ISO | Crmp1 (Mus musculus) | 6480464 | Cisplatin results in increased phosphorylation of CRMP1 protein | CTD | PMID:22006019 | Crmp1 | Rat | D-glucose | multiple interactions | EXP | | 6480464 | CRMP1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] | CTD | PMID:21124846 | Crmp1 | Rat | dibutyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CRMP1 mRNA | CTD | PMID:31199487 | Crmp1 | Rat | diethyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CRMP1 mRNA | CTD | PMID:31199487 | Crmp1 | Rat | diisobutyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CRMP1 mRNA | CTD | PMID:31199487 | Crmp1 | Rat | diisononyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CRMP1 mRNA | CTD | PMID:31199487 | Crmp1 | Rat | dioxygen | multiple interactions | EXP | | 6480464 | CRMP1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] | CTD | PMID:21124846 | Crmp1 | Rat | dioxygen | increases expression | ISO | Crmp1 (Mus musculus) | 6480464 | Oxygen deficiency results in increased expression of CRMP1 protein | CTD | PMID:25937538 | Crmp1 | Rat | disodium selenite | decreases expression | ISO | CRMP1 (Homo sapiens) | 6480464 | Sodium Selenite results in decreased expression of CRMP1 mRNA | CTD | PMID:18175754 | Crmp1 | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of CRMP1 mRNA | CTD | PMID:29391264 | Crmp1 | Rat | epoxiconazole | increases expression | ISO | Crmp1 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of CRMP1 mRNA | CTD | PMID:35436446 | Crmp1 | Rat | ethanol | affects splicing | ISO | Crmp1 (Mus musculus) | 6480464 | Ethanol affects the splicing of CRMP1 mRNA | CTD | PMID:30319688 | Crmp1 | Rat | ethanol | affects expression | ISO | Crmp1 (Mus musculus) | 6480464 | Ethanol affects the expression of CRMP1 mRNA | CTD | PMID:30319688 | Crmp1 | Rat | folic acid | decreases expression | ISO | Crmp1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of CRMP1 mRNA | CTD | PMID:25629700 | Crmp1 | Rat | folic acid | multiple interactions | ISO | Crmp1 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of CRMP1 mRNA] | CTD | PMID:22206623 | Crmp1 | Rat | fonofos | increases methylation | ISO | CRMP1 (Homo sapiens) | 6480464 | Fonofos results in increased methylation of CRMP1 promoter | CTD | PMID:22847954 | Crmp1 | Rat | fulvestrant | multiple interactions | ISO | CRMP1 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of CRMP1 gene | CTD | PMID:31601247 | Crmp1 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of CRMP1 mRNA | CTD | PMID:33387578 | Crmp1 | Rat | glucose | multiple interactions | EXP | | 6480464 | CRMP1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] | CTD | PMID:21124846 | Crmp1 | Rat | ivermectin | decreases expression | ISO | CRMP1 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of CRMP1 protein | CTD | PMID:32959892 | Crmp1 | Rat | methapyrilene | increases methylation | ISO | CRMP1 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of CRMP1 intron | CTD | PMID:30157460 | Crmp1 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CRMP1 mRNA | CTD | PMID:20360939 | Crmp1 | Rat | paracetamol | affects expression | ISO | Crmp1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of CRMP1 mRNA | CTD | PMID:17562736 | Crmp1 | Rat | paracetamol | increases expression | ISO | CRMP1 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of CRMP1 mRNA | CTD | PMID:29067470 | Crmp1 | Rat | parathion | increases methylation | ISO | CRMP1 (Homo sapiens) | 6480464 | Parathion results in increased methylation of CRMP1 promoter | CTD | PMID:22847954 | Crmp1 | Rat | pentanal | increases expression | ISO | CRMP1 (Homo sapiens) | 6480464 | pentanal results in increased expression of CRMP1 mRNA | CTD | PMID:26079696 | Crmp1 | Rat | phenethyl caffeate | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CRMP1 mRNA | CTD | PMID:20360939 | Crmp1 | Rat | pirinixic acid | multiple interactions | ISO | Crmp1 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CRMP1 mRNA | CTD | PMID:19710929 | Crmp1 | Rat | rotenone | affects expression | ISO | Crmp1 (Mus musculus) | 6480464 | Rotenone affects the expression of CRMP1 mRNA | CTD | PMID:23186747 | Crmp1 | Rat | SB 431542 | multiple interactions | ISO | CRMP1 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of CRMP1 protein | CTD | PMID:37664457 | Crmp1 | Rat | selenomethionine | affects expression | ISO | CRMP1 (Homo sapiens) | 6480464 | Selenomethionine affects the expression of CRMP1 mRNA | CTD | PMID:17222674 | Crmp1 | Rat | silicon dioxide | increases expression | ISO | Crmp1 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of CRMP1 mRNA | CTD | PMID:29341224 | Crmp1 | Rat | sodium arsenite | decreases expression | ISO | CRMP1 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of CRMP1 mRNA | CTD | PMID:25879800 | Crmp1 | Rat | sodium arsenite | affects methylation | ISO | CRMP1 (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of CRMP1 gene | CTD | PMID:28589171 | Crmp1 | Rat | sunitinib | decreases expression | ISO | CRMP1 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of CRMP1 mRNA | CTD | PMID:31533062 | Crmp1 | Rat | terbufos | increases methylation | ISO | CRMP1 (Homo sapiens) | 6480464 | terbufos results in increased methylation of CRMP1 promoter | CTD | PMID:22847954 | Crmp1 | Rat | testosterone | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CRMP1 mRNA | CTD | PMID:32741896 | Crmp1 | Rat | thapsigargin | increases expression | EXP | | 6480464 | Thapsigargin results in increased expression of CRMP1 protein | CTD | PMID:35544339 | Crmp1 | Rat | thiram | decreases expression | ISO | CRMP1 (Homo sapiens) | 6480464 | Thiram results in decreased expression of CRMP1 mRNA | CTD | PMID:38568856 | Crmp1 | Rat | titanium dioxide | decreases methylation | ISO | Crmp1 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of CRMP1 gene | CTD | PMID:35295148 | Crmp1 | Rat | titanium dioxide | increases methylation | ISO | Crmp1 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of CRMP1 promoter | CTD | PMID:35295148 | Crmp1 | Rat | urethane | decreases expression | ISO | CRMP1 (Homo sapiens) | 6480464 | Urethane results in decreased expression of CRMP1 mRNA | CTD | PMID:28818685 | Crmp1 | Rat | valproic acid | affects expression | ISO | Crmp1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of CRMP1 mRNA | CTD | PMID:17292431 | Crmp1 | Rat | valproic acid | affects expression | ISO | CRMP1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CRMP1 mRNA | CTD | PMID:25979313 | Crmp1 | Rat | valproic acid | increases expression | ISO | CRMP1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CRMP1 mRNA | CTD | PMID:23179753 and PMID:25192806 | |